Top Stock Ideas Sent Daily — Join and Gain Your Edge
get this deal
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Top Stock Ideas Sent Daily — Join and Gain Your Edge
get this deal
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
NeuroBo Pharmaceuticals
NRBO
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$3.32
0.12
3.75%
At Close: -
$3.28
-0.04
-1.20%
After Hours: Sep 24, 8:52 AM EDT
15 minutes delayed
Get Report
Comment
NeuroBo Pharmaceuticals (NRBO) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for NeuroBo Pharmaceuticals (NASDAQ:NRBO) Stock
NeuroBo Pharmaceuticals Stock (NASDAQ: NRBO)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, August 14, 2024
NeuroBo Pharmaceuticals Q2 EPS $(1.85) Misses...
Benzinga Newsdesk
Tuesday, August 13, 2024
NeuroBo Pharmaceuticals Completes Enrollment ...
Benzinga Newsdesk
Tuesday, August 06, 2024
NeuroBo Pharmaceuticals Together With Dong-A ...
Benzinga Newsdesk
NeuroBo Pharmaceuticals Announces Joint Resea...
Benzinga Newsdesk
Tuesday, July 30, 2024
NeuroBo Pharmaceuticals shares are trading hi...
Benzinga Newsdesk
NeuroBo Pharmaceuticals Signs Exclusive Licen...
Benzinga Newsdesk
Monday, July 01, 2024
Watching NeuroBo Pharmaceuticals; Zacks Small...
Benzinga Newsdesk
Wednesday, June 26, 2024
NeuroBo Pharmaceuticals shares are trading hi...
Benzinga Newsdesk
NeuroBo Pharmaceuticals Doses First Patient i...
Benzinga Newsdesk
NeuroBo Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying
Avi Kapoor
Tuesday, June 25, 2024
NeuroBo Pharmaceuticals shares are trading hi...
Benzinga Newsdesk
Dong-A ST (10%+) Buys 2.54M Shares of NeuroBo...
Benzinga Newsdesk
Monday, June 24, 2024
NeuroBo Pharmaceuticals shares are trading lo...
Benzinga Newsdesk
NeuroBo Pharmaceuticals Entered Into Definiti...
Benzinga Newsdesk
Reported Earlier, NeuroBo's Novel Drug Shows ...
Benzinga Newsdesk
Wednesday, May 22, 2024
NeuroBo Pharmaceuticals Stock Slides Despite Animal Study Showing Wegvoy, Liver Fibrosis Success
Vandana Singh
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
NeuroBo Pharmaceuticals Reports Pre-Clinical ...
Benzinga Newsdesk
Thursday, May 09, 2024
NeuroBo Pharmaceuticals Q1 2024 GAAP EPS $(1....
Benzinga Newsdesk
Wednesday, May 08, 2024
Maxim Group Initiates Coverage On NeuroBo Pha...
Benzinga Newsdesk
Tuesday, April 30, 2024
NeuroBo To Present Latest Pre-Clinical Data O...
Benzinga Newsdesk
Wednesday, April 17, 2024
NeuroBo Pharmaceuticals Doses First Patient I...
Benzinga Newsdesk
Friday, April 12, 2024
NeuroBo Pharmaceuticals Files For Mixed Shelf...
Benzinga Newsdesk
Monday, April 01, 2024
NeuroBo Pharmaceuticals Completes Enrollment ...
Benzinga Newsdesk
Wednesday, March 13, 2024
NeuroBo Pharmaceuticals Receives Safety Revie...
Benzinga Newsdesk
Monday, March 04, 2024
NeuroBo Pharmaceuticals Appoints Marshall H. ...
Benzinga Newsdesk
Thursday, February 29, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
NeuroBo Pharmaceuticals Receives First Site I...
Benzinga Newsdesk
Thursday, February 01, 2024
Dow Jumps 250 Points; Honeywell Issues Weak Forecast
Avi Kapoor
Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Crude Oil Gains 1%; ISM Manufacturing PMI Tops Expectations
Avi Kapoor
Why Obesity-Drug Maker NeuroBo Stock Is Trading Higher
Erica Kollmann
NeuroBo Pharmaceuticals shares are trading hi...
Benzinga Newsdesk
Nasdaq Surges 100 Points; US Jobless Claims Increase To 224,000
Avi Kapoor
Market-Moving News for February 1st
Benzinga Newsdesk
NeuroBo Pharmaceuticals Announces FDA Clearan...
Benzinga Newsdesk
Thursday, January 18, 2024
NeuroBo Reports Pre-Clinical Safety Data Of D...
Benzinga Newsdesk
Tuesday, January 09, 2024
NeuroBo Pharmaceuticals Regains Compliance Wi...
Benzinga Newsdesk
Friday, December 29, 2023
What's Going On With Clinical-Stage Biotech Firm NeuroBo Shares Today?
Nabaparna Bhattacharya
Thursday, December 28, 2023
NeuroBo Pharmaceuticals shares are trading hi...
Benzinga Newsdesk
NeuroBo Pharmaceuticals Submits IND Applicati...
Benzinga Newsdesk
Tuesday, December 19, 2023
NeuroBo Pharmaceuticals shares are trading lo...
Benzinga Newsdesk
NeuroBo Pharmaceuticals Announces 1-For-8 Rev...
Benzinga Newsdesk
Monday, November 13, 2023
NeuroBo Pharmaceuticals Q3 EPS $(0.09) Beats ...
Benzinga Newsdesk
NeuroBo Pharmaceuticals Cash And Cash Equival...
Benzinga Newsdesk
Tuesday, October 31, 2023
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Monday, October 30, 2023
On Oct 25, Eurobo Pharmaceuticals Appointed M...
Benzinga Newsdesk
Friday, September 15, 2023
NeuroBo Pharmaceuticals Doses First Patient I...
Benzinga Newsdesk
Friday, August 18, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch